McKesson vs Sanofi
McKesson (MCK), health care, and Sanofi (SNY), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
McKesson is worth $127B on the stock market and Sanofi $115B: McKesson is valued at 10% more. McKesson trades at 28.4 times earnings and Sanofi at 23.8; operating margins in their latest fiscal years were 1.54% and 14.5%. Over the past year McKesson's share price has moved +28.4% and Sanofi's -4.48%.
Key facts
- McKesson market value
- $127B
- Sanofi market value
- $115B
- McKesson P/E
- 28.4
- Sanofi P/E
- 23.8
- McKesson revenue
- $403.4BFY to 2026-03-31
- Sanofi revenue
- $48.4BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | McKesson | Sanofi |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-03-31 | 2025-12-31 |
| Size | ||
| Market cap | $127Bhigher | $115Blower |
| Revenue | $403.4Bhigher | $48.4Blower |
| Earnings | $4.8Blower | $8.7Bhigher |
| Employees | 41,600lower | 74,846higher |
| Total assets | $82.3Blower | $140.7Bhigher |
| Valuation | ||
| P/E | 28.4higher | 23.8lower |
| P/S | 0.3lower | 2.4higher |
| P/B | — | — |
| Dividend yield | 0.31% | — |
| Profitability | ||
| Operating margin | 1.54%lower | 14.5%higher |
| Balance sheet | ||
| Net assets | -$2.2Blower | $79.2Bhigher |
| Total liabilities | $83.2Bhigher | $61.1Blower |
| Total debt | $6.5Blower | $20.8Bhigher |
| Cash on hand | $4Blower | $8.5Bhigher |
| Price change | ||
| Today | -0.48%higher | -1.05%lower |
| 1 year | +28.4%higher | -4.48%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Charles Brandes (founder)0.8% / 1.2%
McKesson only (12)
- Ron Muhlenkamp (founder)5.7%
- Frank Sands0.6%
- Paul Tudor Jones0.4%
- Stephen Mandel0.3%
- Cliff Asness0.2%
- Jim Simons (1938–2024)0.2%
- David Shaw (founder)0.2%
- Ray Dalio (founder)0.2%
- Ken Griffin0.2%
- Joel Greenblatt0.1%
- Howard Gleicher<0.1%
- Temasek<0.1%
Sanofi only (6)
- Louis Bacon0.5%
- Sarah Ketterer0.4%
- Dodge & Cox team0.3%
- Ken Fisher0.1%
- Lee Ainslie<0.1%
- Richard Pzena<0.1%
Percentages are each holding's share of that investor's reported portfolio (under "Both": McKesson / Sanofi). Who owns MCK · Who owns SNY
More on McKesson
Further comparisons
McKesson against its closest peers
Sanofi against its closest peers
Learn
Questions and answers
Which is bigger, McKesson or Sanofi?
By market value, McKesson is the larger: $127B against $115B for Sanofi. By revenue in its latest fiscal year, McKesson is the larger: $403.4B against $48.4B for Sanofi.
Which has the higher P/E ratio?
McKesson: 28.4, against 23.8 for Sanofi. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Sanofi: 14.5%, against 1.54% for McKesson. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Sanofi: $20.8B, against $6.5B for McKesson. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both McKesson and Sanofi?
In their latest 13F filings, Charles Brandes (founder) holds both.
Cite this page
Funkfolio, “McKesson vs Sanofi”, data as of 17 November 2026. https://funkfolio.com/compare/mck-vs-sny
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.